<noframes id="zd9f3">

    <address id="zd9f3"></address>

    <address id="zd9f3"></address>
    <address id="zd9f3"></address>

    <address id="zd9f3"><nobr id="zd9f3"><meter id="zd9f3"></meter></nobr></address>
    1. Protein Tyrosine Kinase/RTK
    2. Btk


    Bruton tyrosine kinase (Btk) is a member of the Tec family kinases with a well-characterized role in B-cell antigen receptor (BCR)-signaling and B-cell activation.

    Btk plays a crucial role in B cell development and activation through the BCR signaling pathway and represents a new target for diseases characterized by inappropriate B cell activity. Btk is a kinase expressed exclusively in B cells and myeloid cells and has a well characterized, vital role in B cells highlighted by the human primary immune deficiency disease, X-linked agammaglobulinemia (XLA), which results from mutation in the Btk gene. Btk plays an essential role in the BCR signaling pathway. Antigen binding to the BCR results in B cell receptor oligomerization, Syk and Lyn kinase activation, followed by Btk kinase activation. Once activated, Btk forms a signaling complex with proteins such as BLNK, Lyn, and Syk and phosphorylates phospholipase C (PLC)γ2. This leads to downstream release of intracellular Ca2+ stores and propagation of the BCR signaling pathway through extracellular signal-regulated kinase and NF-κB signaling, ultimately resulting in transcriptional changes to foster B cell survival, proliferation, and/or differentiation.

    Btk 相关产品 (37):

    Cat. No. Product Name Effect Purity
    • HY-10997
      Ibrutinib Inhibitor 99.89%
      Ibrutinib (PCI-32765) 是选择性,不可逆的 Btk 抑制剂,IC50 值为 0.5 nM。
    • HY-17600
      Acalabrutinib Inhibitor 99.94%
      Acalabrutinib 是一种新颖的,有效的,选择性的 BTK 抑制剂,在体内试验中 IC50EC50 分别为 3 nM 和 8 nM。
    • HY-19834
      Fenebrutinib Inhibitor 99.50%
      Fenebrutinib (GDC-0853) 是有效,选择性和非共价的布鲁顿酪氨酸激酶 (Btk) 抑制剂,Ki 为0.91 nM。
    • HY-101215
      Evobrutinib Inhibitor 98.17%
      Evobrutinib是 BTK 的抑制剂, 来自专利US20140162983 化合物实例0174。
    • HY-15771
      Tirabrutinib Inhibitor 99.31%
      Tirabrutinib (ONO-4059) 是高选择性,可口服的 BTK 抑制剂, IC50 为2.2 nM。
    • HY-100335
      PCI-33380 Inhibitor 98.33%
      PCI-33380 是布鲁顿酪氨酸激酶 (BTK) 的不可逆抑制剂(荧光探针)。
    • HY-102036
      G-744 Inhibitor
      G-744是有效,选择性的 Btk 抑制剂,IC50 值为2 nM。
    • HY-101474
      (±)-Zanubrutinib Inhibitor 99.70%
      (±)-Zanubrutinib 是一种有效的选择性 Bruton's 酪氨酸激酶 (Btk) 抑制剂。
    • HY-100342
      Ibrutinib-biotin Inhibitor 99.67%
      Ibrutinib-biotin 是一种由 Ibrutinib 通过长链接头连接到生物素上组成的探针,具体可参考 WO2014059368A1 中 Compound 1-5,抑制 BTKIC50 值为 0.755-1.02 nM。
    • HY-18012
      Spebrutinib Inhibitor 99.95%
      Spebrutinib (AVL-292; CC-292) 是共价,高选择性和口服活性的 Btk 抑制剂,IC50 为0.5 nM。
    • HY-101474A
      Zanubrutinib Inhibitor 99.45%
      Zanubrutinib 是一个选择性的 Bruton tyrosine kinase (BTK) 抑制剂。
    • HY-15427
      GDC-0834 Inhibitor 99.07%
      GDC-0834 是一种有效的选择性 BTK 抑制剂。GDC-0834 抑制 BTK,在体外酶实验和细胞实验中,IC50 分别为 5.9 和 6.4 nM,而在小鼠和大鼠体内,IC50 分别为 1.1 和 5.6 μM。
    • HY-109078
      Vecabrutinib Inhibitor 99.96%
      Vecabrutinib 是一种有效的,非共价的 BTKITK 抑制剂,Kd 值分别为 0.3 nM 和 2.2 nM;Vecabrutinib 对 ITK 的 IC50 值为 24 nM。
    • HY-80002
      BMX-IN-1 Inhibitor 98.88%
      BMX-IN-1是BMX 激酶IC50 值为8.0 nM。
    • HY-101941
      BTK IN-1 Inhibitor 98.88%
      BTK IN-1 是一种有效的 BTK 抑制剂,IC50 值 <100 nM。
    • HY-18018
      RN486 Inhibitor 99.38%
      RN486是高活性Btk抑制剂,IC50为4.0 nM。
    • HY-11999
      CGI-1746 Inhibitor
      CGI-1746 是一种有效的,高选择性的 Btk 抑制剂,IC50 值为 1.9 nM。
    • HY-112161
      BMS-986195 Inhibitor 99.56%
      BMS-986195 是一个有效的、布鲁顿氏酪氨酸激酶 (BTK) 的不可逆共价抑制剂,其 IC50 值 <1 nM。
    • HY-112215
      ARQ 531 Inhibitor 98.54%
      ARQ 531 是 BTK 可逆的非共价抑制剂,其对 WT-BTK 和 C481S-BTK 的 IC50 值分别为 0.85 nM 和 0.39 nM。
    • HY-112166
      PRN1008 Inhibitor 99.49%
      PRN1008 是布鲁顿氏酪氨酸激酶 (BTK) 可逆的、选择性的、有口服活性的共价抑制剂,其 IC50 值为 1.3 nM。
    Isoform Specific Products

    Your Search Returned No Results.

    Sorry. There is currently no product that acts on isoform together.

    Please try each isoform separately.